Rapid Case Ascertainment Shared Resource
July 24, 2026Working as an agent of the Connecticut Tumor Registry, the Rapid Case Ascertainment (RCA) Shared Resource facilitates population-based studies of cancer for YCC investigators as well as outside investigators.
Contact
Rajni Mehta, MPH, Director
About the speakers
Information
- ID
- 14354
- To Cite
- DCA Citation Guide
Transcript
- 00:00Hi, everybody. I am Raj
- 00:02Nimehta. I'm the director of
- 00:04the rapid case ascertainment
- 00:06shared resource.
- 00:08And
- 00:09next slide, please.
- 00:11So
- 00:12the rapid case ascertainment resource
- 00:14is a little different from
- 00:16probably what you've heard,
- 00:17because we we work with
- 00:20investigators conducting
- 00:21non therapeutic studies. So you
- 00:23can think of us as
- 00:25you can think of the
- 00:26clinical trials office as the
- 00:28therapeutic,
- 00:30resource,
- 00:31and we are the non
- 00:32therapeutic. So we support,
- 00:35cancer center members
- 00:37in,
- 00:38in studies that are non
- 00:39therapeutic for case identification,
- 00:42study management, patient enrollment, medical
- 00:45record abstraction,
- 00:47and specimen collection so they
- 00:49can accomplish their scientific goals.
- 00:52Next slide.
- 00:55So we have been a
- 00:57YCC shared resource since nineteen
- 00:59ninety five,
- 01:01and we wear several different
- 01:03hats. Right? So we we
- 01:05work as Yale staff to
- 01:07support Yale studies, but we
- 01:09also work,
- 01:12as agents of the Connecticut
- 01:13Tumor Registry through a personal
- 01:15service agreement
- 01:17so we can collect data
- 01:18from
- 01:19outside
- 01:20hospitals that are not Yale.
- 01:22So that's kind of our
- 01:23Connecticut Tumor Registry hat.
- 01:26So in in this personal
- 01:28service agreement, after we get
- 01:30all the approvals,
- 01:31we can assist investigators
- 01:34in identifying cases and collecting
- 01:36specimens from,
- 01:39Connecticut hospitals for our for
- 01:41through the Connecticut Tumor Registry.
- 01:45The cost of RCA
- 01:47is is really the staff
- 01:49time and effort. Right? We
- 01:51we don't have any machines
- 01:53or we don't have any
- 01:54equipment. We just charge
- 01:56for our time and effort
- 01:59devoted
- 02:00to what we do for
- 02:01each investigator,
- 02:02and we do that in
- 02:03two ways. So we have
- 02:04our current,
- 02:07way of one hundred and
- 02:08forty dollars an hour, and
- 02:09that's a fee for service.
- 02:11And as a cancer center
- 02:12member,
- 02:13you get, a fifteen percent,
- 02:15discount
- 02:16on that. So it's a
- 02:17the cancer center pays fifteen
- 02:19percent of that. So you're
- 02:20only charged for the eighty,
- 02:23eighty five percent.
- 02:25And then another way that
- 02:27we recover costs is that
- 02:30some of our staff are
- 02:31dedicated
- 02:32to your study
- 02:34as a percent effort. So
- 02:36many studies
- 02:37cannot,
- 02:38hire a full time person.
- 02:40So if you can hire
- 02:41your full time person, great.
- 02:43You can go and hire
- 02:44them. But many
- 02:45of our studies are smaller,
- 02:47and investigators
- 02:48only have, like, let's say,
- 02:49a twenty percent effort or
- 02:50a ten percent effort. So
- 02:52that's where we can come
- 02:53in,
- 02:54and you can hire somebody
- 02:56at that
- 02:57small effort to help you,
- 02:59and you don't have to
- 03:00hire somebody because you could
- 03:02never,
- 03:03hire somebody at that, level
- 03:05of effort. So that's how,
- 03:07some of our staff, you
- 03:08know, work twenty percent on
- 03:10one study, twenty percent on
- 03:11another study. So so it
- 03:12really helps these smaller
- 03:14investigators who do not have
- 03:16a lot of money,
- 03:17be able to conduct their
- 03:19studies. Because if if, of
- 03:21course, if you have a
- 03:22full time FTE, then it's
- 03:23great. You have somebody dedicated,
- 03:25but we can help you
- 03:26in that way.
- 03:29In in addition to the
- 03:31dedicated effort, just being able
- 03:32to charge you by the
- 03:33hour is something that some
- 03:35investigators like because you don't
- 03:37you only need a certain,
- 03:39let's say, hundred records extracted.
- 03:41Right? So we just say,
- 03:42okay. Can you extract a
- 03:44hundred records for us? We
- 03:45don't
- 03:46it could take us, you
- 03:47know, a couple of months,
- 03:48but we just pay you
- 03:50by the hour that we
- 03:51work on your study.
- 03:53So those are the the
- 03:54two different ways.
- 03:55Next slide.
- 03:57And so, again, these are
- 03:58our key services
- 04:00that we perform. We have
- 04:01a lot of experience with
- 04:03IRB approvals,
- 04:05overall study management.
- 04:07You know, people come to
- 04:08me to say, oh, how
- 04:09do I get this DUA
- 04:10done?
- 04:12Can you help me?
- 04:13How do I pay sites?
- 04:15Can you help me pay
- 04:16sites? And and so these
- 04:17are just,
- 04:18staff,
- 04:19you know, activities that that
- 04:21people need help with. We
- 04:23identify
- 04:24cancer cases. So if you
- 04:26say
- 04:27you need to identify everybody
- 04:29with liver cancer because you
- 04:30wanna do a study,
- 04:32and abstract treatment on liver
- 04:34cancer, so we can help
- 04:36you with that.
- 04:37Again, extracting medical records. Many
- 04:39of our,
- 04:42you know, the IRB protocols
- 04:43require physician consent. So we
- 04:46help investigators
- 04:47identify the patients and then
- 04:48contacting these the their their
- 04:51clinicians for permission to contact
- 04:53them. We screen them. We
- 04:55conduct surveys either in person
- 04:57or,
- 04:58sending them a link. We
- 05:00also collect
- 05:02blood,
- 05:03specimens during their standard of
- 05:05care collection. Some some
- 05:07investigators,
- 05:10wanna collect an additional tube
- 05:11of blood
- 05:12from these, patients that are
- 05:14getting certain treatments
- 05:16or,
- 05:17you know, the COVID vaccine.
- 05:19They wanna test, you know,
- 05:21markers, and so we have
- 05:23done that as well.
- 05:25Same thing for stool and
- 05:26CSF.
- 05:27And we also work with
- 05:29archival pathology specimens.
- 05:32We work with Yale New
- 05:34Haven Hospital with,
- 05:35the shared resource also, and
- 05:38we work collecting specimens from
- 05:40all over the country.
- 05:43Cohorts, for example, everybody who's
- 05:45who has,
- 05:46had, like,
- 05:48liver cancer,
- 05:49through the VA, for example.
- 05:51We've done a study where
- 05:53we collected from all the
- 05:54stations at the VA for
- 05:56patients who had liver cancer.
- 05:58And then it was brought
- 05:59you know, they shipped the
- 06:00specimens. We we worked with
- 06:02the l pathology
- 06:03to section them with our
- 06:04study pathologist,
- 06:06and then we returned these
- 06:07specimens.
- 06:09We also serve as honest
- 06:11brokers, which means that some
- 06:13studies that the investigator has
- 06:15to be blinded.
- 06:16We're able to be that
- 06:18person who that the the
- 06:20the shared resource who knows
- 06:21who these patients are to
- 06:23be able to collect the
- 06:24specimens. But when
- 06:26we give it to the
- 06:26investigator, it's de identified.
- 06:29So the IRBs will usually,
- 06:32exempt those studies because you're
- 06:34not collecting any identifiers.
- 06:36You you we are your
- 06:38middle person, your honest broker
- 06:40to know.
- 06:41We know who they are
- 06:42to collect the data, but
- 06:43you are not getting anything.
- 06:45And, again, some of the
- 06:46other things that we've done
- 06:48is collecting films,
- 06:49radiology scans. So we work
- 06:51with investigators.
- 06:53If they wanna collect anything,
- 06:55we we can help you
- 06:57and and kinda brainstorm how
- 06:58to do this.
- 06:59Next slide.
- 07:01So this is just a
- 07:03really quick example of the
- 07:05studies that we've done.
- 07:08So prospective identification
- 07:10with surveys and pathology collections.
- 07:12These, again, newly diagnosed.
- 07:15We do you know, I've
- 07:17talked a little bit about
- 07:18this where we can,
- 07:20we can consent the patient.
- 07:22We can collect,
- 07:23some a survey. We can
- 07:25collect their specimens.
- 07:28We do this, again, also
- 07:29retrospectively.
- 07:30Like, there's a a retrospective
- 07:32cohort of ten years of,
- 07:34let's say,
- 07:36brain tumors,
- 07:38and we can go back
- 07:39and do a whole medical
- 07:40record abstraction, collect their slide
- 07:42their blocks,
- 07:44collect imaging, everything.
- 07:47Number three is, again, our
- 07:48our work with our connect
- 07:50with the Connecticut Tumor Registry.
- 07:51This is like our our
- 07:53kinda Connecticut Tumor Registry hat
- 07:55a little bit differently than
- 07:56as working as a Yale
- 07:58employee.
- 08:00And we we can collect,
- 08:02specimens, medical record abstraction
- 08:06for,
- 08:07any, you know, any patient
- 08:09diagnosed in Connecticut.
- 08:11As you know,
- 08:12any cancer diagnosis is reportable
- 08:15to the Connecticut Tumor Registry,
- 08:16so they
- 08:18have everybody who's been diagnosed
- 08:20with cancer. It's the oldest,
- 08:22tumor registry in the country.
- 08:25And then, again, our, like
- 08:27I've said before, we also
- 08:28can collect,
- 08:30blood, stools. We've done some
- 08:31of these,
- 08:33CSF collections that investigators need.
- 08:35We we bring the tubes,
- 08:37and then when they're getting
- 08:38their CSF or their biopsy,
- 08:40we then,
- 08:41transport that back to the
- 08:43lab that's gonna be,
- 08:46analyzing that.
- 08:48Next slide.
- 08:51So just I've touched a
- 08:52little bit about this, but
- 08:53the benefits
- 08:54is that we we have
- 08:57a lot of experience.
- 08:59I've been this I've been
- 09:00doing this for twenty five
- 09:01years in this position. We
- 09:03have Rocco who's been here
- 09:04for thirty five years, forty
- 09:06years.
- 09:08So we we've have a
- 09:10lot of experience in in
- 09:12lab experience
- 09:13and IRB experience. We're very
- 09:15flexible.
- 09:17I usually meet with every
- 09:19investigator that wants to use
- 09:21RCA just to kinda guide
- 09:22them. You don't have to
- 09:23use me. A lot of
- 09:24times, they're like, oh, thank
- 09:25you for letting me know
- 09:26I could do this. So
- 09:27I'm here just for to
- 09:29also provide guidance,
- 09:30through study planning,
- 09:33just to give you just,
- 09:35ideas and how to better
- 09:37do your study. If you
- 09:38don't have any funding, I've
- 09:39still I can still help
- 09:40you. You know, I'm happy
- 09:41to meet with anybody
- 09:43just to guide you on
- 09:44what you need to do.
- 09:45I do this all the
- 09:46time. How do I apply
- 09:47for IRB?
- 09:49So I'm here to, you
- 09:50know, support anybody here at
- 09:52the cancer center.
- 09:54Next slide.
- 09:56So here's my email.
- 09:58Please feel free to reach
- 09:59out,
- 10:01and I can, you know,
- 10:02try to help you in
- 10:03any way I can.